- Dyne Therapeutics (NASDAQ:DYN) announces the pricing of an underwritten public offering of 17.15 million shares of its common stock at a public offering price of $17.50 per share, for an expected gross proceeds to be approximately $300.1 million.
- All shares in the offering are being sold by Dyne.
- The offering is expected to close on or about January 9, 2024.
- The company said it expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 2.57 million shares of its common stock at the public offering price.
Trending
- ‘I want to die “young” as late as possible,’ says 83-year-old triathlete doctor who reinvented himself after a midlife crisis
- 10 Israeli Soldiers Hospitalized After Wasp Swarm Attack
- Construction Partners posts strong Q2 amid high demand By Investing.com
- ZIM Integrated sails to top industrial gainer of week, Builders FirstSource sees loser tag
- US Marine Says 40% of Drones the IDF Has Shot Down Were Their Own
- Amprius Technologies doubles customer base, boosts revenue By Investing.com
- My 19-year-old son wants to get married so Uncle Sam will ‘kick in more scratch’ for his girlfriend’s financial aid. Is this a terrible idea?
- Meet the Doomsayers Waiting for the Economy to Crash
Wednesday, July 30
Dyne Therapeutics prices stock offering to raise $300.1 million
By 
